IMUNON and NCI Advance IMNN-001 Clinical Development
LAWRENCEVILLE, N.J. — September 10, 2026 IMUNON, Inc. announced a Cooperative Research and Development Agreement (CRADA) with the National...
NCI
Advertisement
Kyowa Kirin Advances AI-Powered Drug Discovery R&D
Tokyo, Japan, August 16, 2026 Kyowa Kirin Co., Ltd. has selected Cognizant and Benchling as partners to implement an...
Actinium Advances Actimab-A With Manufacturing Expansion
New York, United States, August 14, 2026 Actinium Pharmaceuticals, Inc. announced new intellectual property and manufacturing developments supporting its...
Olio Labs AI Platform Predicts Human Drug Trial Outcomes
South San Francisco, California, August 6, 2026 Olio Labs has presented a new AI-driven in vivo drug discovery platform...
CSHL and Northwell Build 150+ Next-Gen Cancer Models
Cold Spring Harbor, New York, August 5, 2026 Cold Spring Harbor Laboratory (CSHL) and Northwell Health have helped lead...
Advertisements
FibroBiologics Secures European Patent for Cartilage Gene Therapy
Houston, Texas, August 5, 2026 FibroBiologics, Inc. has strengthened its global intellectual property portfolio after the European Patent Office...
NIH Expands Human Cancer Models for Precision Oncology
Bethesda, Maryland, August 5, 2026 The National Institutes of Health (NIH), through the National Cancer Institute (NCI) and its...
PDS Biotech Reports Breakthrough Phase 2 mCRC Results
Princeton, New Jersey, U.S. | April 15, 2026 PDS Biotechnology has announced the publication of positive interim Phase 2...
Senhwa’s CX-5461 Gains FDA IND Clearance and NCI Support to Advance in MYC-Driven Lymphoma
Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has...
Advertisement
